4.8 Article

Report of the National Heart, Lung, and Blood Institute Working Group on the Translation of Cardiovascular Molecular Imaging

Journal

CIRCULATION
Volume 123, Issue 19, Pages 2157-2163

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.110.000943

Keywords

cardiovascular diseases; molecular imaging; diagnosis

Funding

  1. NHLBI, National Institutes of Health
  2. GE Healthcare
  3. Roche
  4. Novartis
  5. GlaxoSmithKline
  6. Bristol Myers Squibb
  7. VBL Therapeutics
  8. Merck
  9. Astra Zeneca
  10. Rigel Pharmaceuticals
  11. Lantheus Medical Imaging
  12. Astellas Pharma
  13. Molecular Targeting Technologies
  14. CDL Nuclear Technologies

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available